Digital Breast Tomosynthesis (DBT) Equipment Market Report, By Product Type (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems), By End-Users (Hospitals, Diagnostic Centers, and others) and Regions 2024-2032.

Market Overview:

"The digital breast tomosynthesis equipment market size reached US$ 3.3 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 9.2 billion by 2032, exhibiting a growth rate (CAGR) of 12.1% during 2024-2032."

Digital Breast Tomosynthesis (DBT) equipment is an advanced mammography technology that generates three-dimensional images of the breast. Unlike traditional 2D mammography, which produces flat images, DBT captures multiple images from various angles as the X-ray tube moves in an arc over the breast. These images are reconstructed into thin, high-resolution slices, enabling radiologists to examine the breast tissue layer by layer. DBT offers several advantages over 2D mammography, including improved cancer detection rates, better visualization of breast tissue, and reduced false positives. It is particularly useful for women with dense breast tissue, helping to distinguish between overlapping structures and potential tumors.

The market for Digital Breast Tomosynthesis (DBT) equipment is growing rapidly, fueled by growing awareness of its benefits in breast cancer screening, including enhanced diagnostic accuracy and lower recall rates. Technological advancements, such as improved 3D imaging and software enhancements for better image quality, are also driving this growth. Furthermore, the increasing incidence of breast cancer, particularly among women aged 40 and older, is boosting the demand for DBT equipment. Government and healthcare organizations' initiatives to encourage early breast cancer detection are also contributing to the market's expansion.

Digital Breast Tomosynthesis (DBT) Equipment Market Trends and Drivers:

The Digital Breast Tomosynthesis (DBT) equipment market is being shaped by notable trends and drivers. One trend is the increasing preference for DBT systems over traditional mammography due to their superior imaging quality and enhanced cancer detection rates, driving demand among healthcare providers and patients. Additionally, the market is driven by the rising global incidence of breast cancer, prompting a higher demand for advanced diagnostic technologies like DBT. Government initiatives promoting early cancer detection, the shift towards value-based healthcare, and technological advancements in 3D imaging and AI integration are further propelling the adoption of DBT systems, indicating continued market growth ahead.

The digital breast tomosynthesis (DBT) equipment market growth is influenced by several factors such as increasing preference for DBT systems over traditional mammography for breast cancer screening, driven by their superior imaging quality and enhanced cancer detection rates. Additionally, rising global breast cancer incidence rates contribute to a higher demand for advanced diagnostic technologies like DBT. Government initiatives promoting early cancer detection, the adoption of value-based healthcare models, and technological advancements such as 3D DBT systems and AI integration also play significant roles in driving market growth. These factors collectively indicate a sustained growth trajectory for the DBT equipment market in the foreseeable future.

Digital Breast Tomosynthesis (DBT) Equipment Market Restraining Factors:

Several factors restrain the digital breast tomosynthesis (DBT) equipment market. High initial costs for purchasing and installing DBT systems can be a barrier, especially for smaller healthcare facilities. Limited insurance coverage and reimbursement issues for DBT screenings in some regions also hinder market growth. Furthermore, specialized training for radiologists and technologists to interpret DBT images, along with concerns about overdiagnosis and false positives, pose additional challenges. Competition from other breast imaging modalities and regulatory hurdles related to approvals and standards further restrain market expansion.

Digital Breast Tomosynthesis (DBT) Equipment Market Opportunities:

The digital breast tomosynthesis (DBT) equipment market presents various opportunities for growth. As there is a growing emphasis on the early detection and precise diagnosis of breast cancer, the demand for advanced imaging technologies like DBT is increasing. Technological advancements, including the enhancement of 3D DBT systems and the integration of artificial intelligence (AI) for image analysis, are improving the accuracy and effectiveness of breast cancer screening. Moreover, the increasing healthcare spending in developing nations and the rising awareness about the advantages of DBT among healthcare providers and patients are additional factors driving market expansion.

Digital Breast Tomosynthesis (DBT) Equipment Market Segmentation:

By Product Type

• 2D/3D Combination Mammography Systems
• Standalone 3D Mammography Systems

The product type segment comprises of 2D/3D combination mammography systems, and standalone 3D mammography systems. Among these, the 2D/3D combination mammography systems currently hold a dominant position. These systems offer a comprehensive approach to breast imaging by combining the benefits of both 2D and 3D imaging modalities. They provide radiologists with a more detailed and accurate view of breast tissue, leading to improved detection of abnormalities and reduced false positives compared to traditional 2D mammography. The integration of 3D technology into these systems has significantly enhanced their diagnostic capabilities, making them a preferred choice for many healthcare providers seeking advanced breast imaging solutions.

By End-Users

• Hospitals
• Diagnostic Centers
• Others

The end-users segment comprises of hospitals, diagnostic centers and others. Among these, hospitals emerge as the dominant end-user segment. Equipped with comprehensive healthcare facilities, hospitals exhibit a strong demand for advanced imaging technologies like DBT to enhance their diagnostic capabilities. The integration of DBT into hospital settings allows for more accurate and detailed imaging of breast tissue, aiding in the early detection of breast cancer and other abnormalities. Additionally, hospitals often cater to a large patient population, further driving the demand for DBT equipment. While diagnostic centers and other healthcare facilities also utilize DBT, hospitals remain at the forefront of adopting and implementing this technology, establishing them as the leading end-user segment in the DBT equipment market.

By Region  

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Poland
• Benelux
• Nordic
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• ASEAN
• Australia & New Zealand
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA

North America stands out as the dominant force in the Digital Breast Tomosynthesis (DBT) Equipment market, leading the charge in advancing breast imaging technologies. This region, particularly the United States and Canada, demonstrates a high adoption rate of DBT equipment, fueled by its robust healthcare infrastructure and a strong emphasis on early breast cancer detection. Key industry players are heavily concentrated in North America, driving market growth through innovative solutions. Moreover, government initiatives and reimbursement policies further bolster the widespread adoption of DBT equipment in the region. The continued dominance of North America in the DBT equipment market underscores its pivotal role in shaping the future landscape of breast imaging technologies.

Leading Digital Breast Tomosynthesis (DBT) Equipment Providers & Competitive Landscape:

The digital breast tomosynthesis (DBT) equipment market is highly competitive, with several key players vying for market share and actively engaging in strategic initiatives. These companies focus on product innovation, technological advancements, and expanding their product portfolios to gain a competitive edge. These companies are continuously investing in research and development activities to enhance their product offerings and cater to the evolving needs of customers in terms of efficiency, performance, and sustainability.

These companies include:

• GE Healthcare
• Siemens Healthineers
• Hologic Inc.
• Canon Medical
• FUJIFILM Holdings Corporation
• General Electric Company
• Internazionale Medico Scientifica
• PLANMED OY
• Analogic Corporation
• Trivitron Healthcare

Recent News and Development

• August 2022: Whiterabbit unveiled its ACT software, designed to aid in the diagnosis of breast cancer by automatically analyzing digital breast tomosynthesis images, commonly referred to as 3D mammograms.
• May 2022: Therapixel secured EUR 15 million in Series B funding to enhance its commercial footprint in the United States. The funding will also facilitate the launch of additional features for its MammoScreen platform and further advance the capabilities of its reading aid for mammography.

Digital Breast Tomosynthesis (DBT) Equipment Market Research Scope